We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

281 hedge funds and large institutions have $7.27B invested in PHARMACYCLICS INC in 2014 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 95 increasing their positions, 93 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 19

12% more funds holding

Funds holding: 250281 (+31)

8% more capital invested

Capital invested by funds: $6.76B → $7.27B (+$515M)

2% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 93

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

24% less call options, than puts

Call options by funds: $100M | Put options by funds: $132M

Holders
281
Holders Change
+31
Holders Change %
+12.4%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
53
Increased
95
Reduced
93
Closed
19
Calls
$100M
Puts
$132M
Net Calls
-$32.4M
Net Calls Change
+$71.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Canada Pension Plan Investment Board
176
Canada Pension Plan Investment Board
Ontario, Canada
$613K +$115K +900 +22%
Edgewood Management
177
Edgewood Management
Connecticut
$611K
FANJ
178
Financial Architects (New Jersey)
New Jersey
$611K
WS
179
Wedbush Securities
California
$603K -$54.3K -425 -8%
CSS
180
Cubist Systematic Strategies
Connecticut
$595K -$486K -3,803 -44%
Stifel Financial
181
Stifel Financial
Missouri
$591K +$619K +4,841 New
SI
182
Shaker Investments
Ohio
$562K
HHC
183
Hutchin Hill Capital
New York
$550K +$575K +4,500 New
QIM
184
Quantitative Investment Management
Virginia
$525K +$550K +4,300 New
Bessemer Group
185
Bessemer Group
New Jersey
$524K +$5.11K +40 +0.9%
MLICM
186
Metropolitan Life Insurance Company (MetLife)
New York
$524K +$14.6K +114 +3%
Janus Henderson Group
187
Janus Henderson Group
United Kingdom
$510K
FHC
188
First Heartland Consultants
Missouri
$506K
KBC Group
189
KBC Group
Belgium
$504K +$187K +1,464 +55%
NPC
190
National Planning Corporation
California
$464K +$1.15K +9 +0.2%
SI
191
Stephens Inc
Arkansas
$458K -$31.8K -249 -6%
LPL Financial
192
LPL Financial
California
$456K -$230K -1,802 -33%
RFC
193
Regions Financial Corp
Alabama
$451K +$3.32K +26 +0.7%
Truist Financial
194
Truist Financial
North Carolina
$449K +$52.1K +408 +12%
LOAMS
195
Lombard Odier Asset Management (Switzerland)
Switzerland
$442K -$281K -2,195 -38%
LOAME
196
Lombard Odier Asset Management (Europe)
United Kingdom
$442K +$460K +3,600 New
AG
197
Aperio Group
California
$440K +$83.8K +656 +22%
NERM
198
New England Research & Management
Illinois
$407K +$6.39K +50 +2%
Fisher Asset Management
199
Fisher Asset Management
Washington
$399K +$2.56K +20 +0.6%
DL
200
Delta Lloyd
Netherlands
$396K

PCYC Hedge Fund Activity: Q4 2014 in Review

281 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q4 2014, worth a combined $7.27B — up 7.6% from $6.76B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new PCYC positions and 19 closed out — a net gain of 34 holders — while 95 added to existing stakes and 93 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $136M. The largest seller was Baker Bros. Advisors, cutting an estimated $67.4M.

  • 281 institutional investors held PHARMACYCLICS INC (PCYC) as of Q4 2014, up from 250 in Q3 2014.
  • Funds reported $7.27B of PHARMACYCLICS INC stock for Q4 2014, up 7.6% quarter-over-quarter.
  • 53 funds opened new PHARMACYCLICS INC positions in Q4 2014 and 19 closed out, a net change of +34 holders.
  • The largest PHARMACYCLICS INC buyer in Q4 2014 was Janus Henderson Investors US, an estimated $136M added.
  • The largest PHARMACYCLICS INC seller in Q4 2014 was Baker Bros. Advisors, an estimated $67.4M sold.

Based on aggregated 13F filings for Q4 2014.